Skip to content

Vera Therapeutics, Inc.

VERA Nasdaq SEC CIK 1831828

Follow Vera Therapeutics Weekly email: filings, results, news

News

5 stories filed under Vera Therapeutics, grouped into ongoing threads

CEO marshall

Thread · 3 stories

Vera Therapeutics president and CEO Marshall Fordyce sells $1.96m in stock

Markets 42 d ago 2 sources

Vera Therapeutics CEO Marshall Fordyce sells $679,747 in stock

Markets 42 d ago

Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock

Markets 42 d ago

More coverage

Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy

Markets 38 d ago

Goldman Sachs lowers Vera Therapeutics stock price target to $80

Markets 43 d ago also on GS

Profile

Headquarters: BRISBANE, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 5 stories clustered from the RSS aggregator